Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 3

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 3(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04164589Not ApplicableUnknown

EFFECTIVENESS OF THE NEUROADAPTATIVE FOR URGE INCONTINENCE

Role: lead

NCT01915979Phase 3Completed

Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy

Role: lead

NCT02046772Phase 4Completed

Safety and Efficacy of the Addition of Morphine Chloride to a Low Dose of Bupivacaine as Intradural Anaesthetic for the Removal Surgery of the Hemorrhoids

Role: lead

NCT02000752Not ApplicableCompleted

Influence of Acupuncture in the Placental Expulsion Time

Role: lead

NCT02539121Not ApplicableUnknown

Influence of Acupuncture in the Postpartum Blood Loss

Role: lead

NCT02039531Phase 3Completed

Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis

Role: lead

All 6 trials loaded